Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,290.00
-90.00 (-1.41%)
Oct 31, 2025, 1:40 PM KST

Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 382.88 billion. The enterprise value is 441.72 billion.

Market Cap382.88B
Enterprise Value 441.72B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

Bio Plus has 60.01 million shares outstanding. The number of shares has increased by 5.97% in one year.

Current Share Class 60.01M
Shares Outstanding 60.01M
Shares Change (YoY) +5.97%
Shares Change (QoQ) +1.48%
Owned by Insiders (%) 32.08%
Owned by Institutions (%) 6.05%
Float 40.43M

Valuation Ratios

The trailing PE ratio is 26.45.

PE Ratio 26.45
Forward PE n/a
PS Ratio 4.29
PB Ratio 2.23
P/TBV Ratio 2.62
P/FCF Ratio n/a
P/OCF Ratio 17.65
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.14, with an EV/FCF ratio of -7.28.

EV / Earnings 27.25
EV / Sales 4.95
EV / EBITDA 14.14
EV / EBIT 16.07
EV / FCF -7.28

Financial Position

The company has a current ratio of 0.54, with a Debt / Equity ratio of 0.34.

Current Ratio 0.54
Quick Ratio 0.34
Debt / Equity 0.34
Debt / EBITDA 1.84
Debt / FCF -0.95
Interest Coverage 90.96

Financial Efficiency

Return on equity (ROE) is 12.84% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE) 12.84%
Return on Assets (ROA) 7.71%
Return on Invested Capital (ROIC) 9.03%
Return on Capital Employed (ROCE) 15.80%
Revenue Per Employee 713.30M
Profits Per Employee 129.67M
Employee Count 125
Asset Turnover 0.40
Inventory Turnover 2.93

Taxes

Income Tax -1.51B
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +17.91% in the last 52 weeks. The beta is 0.56, so Bio Plus's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change +17.91%
50-Day Moving Average 6,381.80
200-Day Moving Average 6,980.35
Relative Strength Index (RSI) 45.40
Average Volume (20 Days) 448,485

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 89.16 billion and earned 16.21 billion in profits. Earnings per share was 241.25.

Revenue89.16B
Gross Profit 58.98B
Operating Income 27.70B
Pretax Income 19.07B
Net Income 16.21B
EBITDA 31.45B
EBIT 27.70B
Earnings Per Share (EPS) 241.25
Full Income Statement

Balance Sheet

The company has 15.96 billion in cash and 57.81 billion in debt, giving a net cash position of -41.85 billion or -697.34 per share.

Cash & Cash Equivalents 15.96B
Total Debt 57.81B
Net Cash -41.85B
Net Cash Per Share -697.34
Equity (Book Value) 171.36B
Book Value Per Share 2,622.08
Working Capital -43.82B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.69 billion and capital expenditures -82.35 billion, giving a free cash flow of -60.66 billion.

Operating Cash Flow 21.69B
Capital Expenditures -82.35B
Free Cash Flow -60.66B
FCF Per Share -1,010.88
Full Cash Flow Statement

Margins

Gross margin is 66.15%, with operating and profit margins of 31.07% and 18.18%.

Gross Margin 66.15%
Operating Margin 31.07%
Pretax Margin 21.39%
Profit Margin 18.18%
EBITDA Margin 35.27%
EBIT Margin 31.07%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.78%.

Dividend Per Share 50.00
Dividend Yield 0.78%
Dividend Growth (YoY) -28.57%
Years of Dividend Growth n/a
Payout Ratio 17.99%
Buyback Yield -5.97%
Shareholder Yield -5.19%
Earnings Yield 4.23%
FCF Yield -15.84%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date Nov 23, 2022
Split Type Forward
Split Ratio 4

Scores

Bio Plus has an Altman Z-Score of 3.16 and a Piotroski F-Score of 7.

Altman Z-Score 3.16
Piotroski F-Score 7